Use of Omalizumab is Associated with Improvement of Pruritic Skin Disorders Induced by Immune Checkpoint Inhibitors: A Retrospective Cohort from the European Task Force of Dermatology for Cancer Patients.
Journal of the American Academy of Dermatology（2024）
Key words
cancer,immune checkpoint inhibitors,immune-related cutaneous adverse events,omalizumab,pruritus
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined